HBOT pharmacokinetics at 71 ATA: why the research still matters

The UHMS research archive holds decades of primary research including pharmacokinetic studies at extreme pressures — like the referenced work on antipyrine, paracetamol, and morphine kinetics in rat at 71 ATA. Modern clinical HBOT operates at a fraction of that pressure, but the underlying physiology of drug clearance under pressure remains directly relevant to any program dosing medications during chamber treatment.

Practitioners running programs with pain management, sedation for pediatric patients, or complex medication schedules should not treat drug administration inside a chamber as identical to administration at surface pressure. Elimination pathways, tissue distribution, and enzyme activity all shift with pressurization. The research literature — including UHMS-archived work — is the reason experienced medical directors write chamber-specific medication protocols.

Chamber selection matters here because pressure envelope, seal integrity, and monitoring instrumentation determine what protocols a facility can actually run. A chamber rated to 2.0 ATA is a different clinical tool than one rated to 3.0 ATA. Prestige Hyperbaric helps operators think through pressure requirements against clinical protocol before purchase, not after.

Talk to us at prestigehyperbaric.com.

Source: UHMS Research Archive